Dr. Mayank Kumar Mittal, MD

Dr. Mittal practices at Memorial Hospital of South Bend in South Bend, Indiana, part of Beacon Health System.

Dr. Mittal's NPI, 1003044702, was assigned on July 1, 2009. Dr. Mittal holds Indiana license 01078863A.

Dr. Mittal's primary practice is Memorial Hospital of South Bend, at 615 N Michigan St, South Bend, IN 46601 in St. Joseph County. The practice phone is (574) 647-1000.

Dr. Mittal's primary practice is Memorial Hospital of South Bend in South Bend, Indiana, part of Beacon Health System. Dr. Mittal is also affiliated with Franciscan Health Michigan City. The medical group on file is Beacon Medical Group Schwartz-Wiekamp. Dmand AI also links Dr. Mittal to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mittal practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Mittal's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Mittal is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Mittal's licenses on file in 3 states: Indiana, Michigan and Missouri.

CMS data shows 2,599 Medicare services from Dr. Mittal across 33 procedure codes in 2024, for 881 Medicare patients. Medicare paid $178,849 for them.

CMS counts 881 Medicare patients who saw Dr. Mittal in 2024. The largest group is 65 to 74, with 367 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mittal's median patient age at 76, with 46% women.

In 2024, Dr. Mittal wrote 4,519 Medicare Part D claims for 764 patients. 87% of them were for generic drugs. CMS names the drug for 4,349 of them, across 48 drugs with 11 or more claims each, at $659,420 in total drug cost. In 2023, CMS named 4,072 claims across 43 drugs.

Dr. Mittal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mittal as offering telehealth. CMS counts 49 procedures of coronary angioplasty and stenting by Dr. Mittal, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Mittal, published from 2012 to 2020. 2014 was the busiest year, with 3. The most frequent topics are Clinical Competence, Educational Measurement and Educational Status. Dr. Mittal has published most often in Simul Healthc. Dr. Mittal's most frequent co-authors are Harsh Agrawal, MD, Martin A. Alpert, MD and Jon Benjamin Morris, MD.

Dmand AI links Dr. Mittal to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 722 general payments to Dr. Mittal from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 45% of the total. Boston Scientific Corporation paid the most, $15,588.